United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - terbinafine hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

haleon uk ltd - terbinafine - cutaneous gel - 10mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - terbinafine hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - terbinafine hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - terbinafine hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - terbinafine hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - terbinafine hydrochloride - oral tablet - 250mg

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - terbinafine hydrochloride - tablet - terbinafine hydrochloride 250 mg - antifungals for dermatological use

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - terbinafine - tablet - 250 milligram(s) - antifungals for systemic use; terbinafine

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - terbinafine hydrochloride, quantity: 140.625 mg (equivalent: terbinafine, qty 125 mg) - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose monohydrate; microcrystalline cellulose; magnesium stearate; hypromellose - treatment of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as trichophyton (e.g. t. rubrum, t.mentagrophytes, t.verrucosum, t.violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to other available treatments. onychomycosis (fungal infection of the nail) caused by dermatophyte fungi.